Methods for increasing efficacy of folr1 cancer therapy
- 专利权人:
- IMMUNOGEN INC.
- 发明人:
- Carrigan Christina N.,Whiteman Kathleen R.,Payne Gillian,Ladd Sharron
- 申请号:
- NZ71137512
- 公开号:
- NZ711375A
- 申请日:
- 2012.03.30
- 申请国别(地区):
- NZ
- 年份:
- 2017
- 代理人:
- 摘要:
- Disclosed is a method of identifying a tumour as sensitive to treatment with an anti-Folate Receptor 1 (FOLR1) antibody.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- THERAPEUTIC USE OF ANTI- TWEAK RECEPTOR ANTIBODIES TO TREAT CANCER
- Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies
- FRIZZLED RECEPTOR ANTIBODIES FOR TREATMENT OF CANCER
- Anti-FGFR2 Antibodies in Combination with Chemotherapy Agents in Cancer Treatment
- Anti-FGFR2 antibodies in combination with chemotherapy agents in cancer treatment